• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
CMB 0.00% 37.0¢

CAMBIUM BIO LIMITED

Cambium Bio Limited, formerly Regeneus Ltd, is an Australia-based clinical-stage... Cambium Bio Limited, formerly Regeneus Ltd, is an Australia-based clinical-stage regenerative medicine company focusing on the development of biologics for ophthalmology and tissue repair applications. Its technology, based on human platelet lysate, is being leveraged to create a pipeline of novel therapeutics, with a primary focus on ophthalmology. Its lead product candidate, Elate Ocular, is being developed to address significant unmet medical needs in the treatment of dry eye disease. Elate Ocular is formulated from the processing of base human platelets sourced not from patients, but generally healthier younger eligible donors at U.S. blood collection centers. In addition, its stem cell platform, Progenza, is being applied to the development of therapies for knee osteoarthritis and other tissue repair indications. It also manufactures and sells stem cell growth supplements, such as UltraGRO Advanced, UltraGRO Pure (xeno-free), and UltraGRO Pure GI (xeno-free, gamma irradiated).More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
CMB 06/02/25 3 630
06/02/25 Last post  Prorata Comments Created with Sketch.  3  Views Created with Sketch.  630 
CMB 30/01/25 0 133
30/01/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  133 
CMB 07/01/25 0 264
Metals & Mining SECTOR NEWS

China Imposes Molybdenum Export Controls Sparking Demand for US Suplier

EVR
11 Feb 2025
EV RESOURCES LTD
07/01/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  264 
CMB 03/01/25 4 1.7K
03/01/25 Last post  christophe Comments Created with Sketch.  4  Views Created with Sketch.  1.7K 
CMB
CAMBIUM BIO
18/12/24 1 956
18/12/24 Last post  mapp Comments Created with Sketch.  1  Views Created with Sketch.  956 
CMB 12/12/24 0 230
12/12/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  230 
CMB 12/12/24 0 270
12/12/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  270 
CMB 09/12/24 0 394
09/12/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  394 

See All Discussions arrow Created with Sketch.

Timeline

Quarterly Activities/Appendix 4C Cash Flow Report
31 Jan 13:21
 
Notice of General Meeting/Proxy Form
30 Jan 11:14
 
Change in substantial holding
07 Jan 10:42
 
Placement Shares Cleansing Notice
12 Dec 15:30
 
Application for quotation of securities - CMB
12 Dec 15:29
 
FDA Grants Fast Track Designation
09 Dec 10:56
 
View More arrow Created with Sketch.
(20min delay)
Last
37.0¢
Change
0.000(0.00%)
Mkt cap ! $4.913M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
1 5000 38.0¢
 

Sellers (Offers)

Price($) Vol. No.
43.0¢ 23993 2
View Market Depth
Last trade - 16.12pm 11/02/2025 (20 minute delay) ?
CMB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.